These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators. Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z J Med Chem; 2007 Aug; 50(16):3857-69. PubMed ID: 17636947 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I. Aikawa K; Miyawaki T; Hitaka T; Imai YN; Hara T; Miyazaki J; Yamaoka M; Kusaka M; Kanzaki N; Tasaka A; Shiraishi M; Yamamoto S Bioorg Med Chem; 2015 May; 23(10):2568-78. PubMed ID: 25862209 [TBL] [Abstract][Full Text] [Related]
8. Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffold. Sun C; Robl JA; Wang TC; Huang Y; Kuhns JE; Lupisella JA; Beehler BC; Golla R; Sleph PG; Seethala R; Fura A; Krystek SR; An Y; Malley MF; Sack JS; Salvati ME; Grover GJ; Ostrowski J; Hamann LG J Med Chem; 2006 Dec; 49(26):7596-9. PubMed ID: 17181141 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats. Ostrowski J; Kuhns JE; Lupisella JA; Manfredi MC; Beehler BC; Krystek SR; Bi Y; Sun C; Seethala R; Golla R; Sleph PG; Fura A; An Y; Kish KF; Sack JS; Mookhtiar KA; Grover GJ; Hamann LG Endocrinology; 2007 Jan; 148(1):4-12. PubMed ID: 17008401 [TBL] [Abstract][Full Text] [Related]
10. Serendipitous discovery of novel imidazolopyrazole scaffold as selective androgen receptor modulators. Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z Bioorg Med Chem Lett; 2007 Jan; 17(2):439-43. PubMed ID: 17079140 [TBL] [Abstract][Full Text] [Related]
11. Selective androgen receptor modulator activity of a steroidal antiandrogen TSAA-291 and its cofactor recruitment profile. Hikichi Y; Yamaoka M; Kusaka M; Hara T Eur J Pharmacol; 2015 Oct; 765():322-31. PubMed ID: 26335395 [TBL] [Abstract][Full Text] [Related]
12. Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator. van Oeveren A; Motamedi M; Mani NS; Marschke KB; López FJ; Schrader WT; Negro-Vilar A; Zhi L J Med Chem; 2006 Oct; 49(21):6143-6. PubMed ID: 17034117 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and SAR of novel hydantoin derivatives as selective androgen receptor modulators. Zhang X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z Bioorg Med Chem Lett; 2006 Nov; 16(22):5763-6. PubMed ID: 16959487 [TBL] [Abstract][Full Text] [Related]
14. A novel synthetic androgen receptor ligand, S42, works as a selective androgen receptor modulator and possesses metabolic effects with little impact on the prostate. Min L; Yanase T; Tanaka T; Fan W; Nomura M; Kawate H; Okabe T; Takayanagi R; Nawata H Endocrinology; 2009 Dec; 150(12):5606-16. PubMed ID: 19854864 [TBL] [Abstract][Full Text] [Related]
15. A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice. Chisamore MJ; Gentile MA; Dillon GM; Baran M; Gambone C; Riley S; Schmidt A; Flores O; Wilkinson H; Alves SE J Steroid Biochem Mol Biol; 2016 Oct; 163():88-97. PubMed ID: 27106747 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators. Marhefka CA; Gao W; Chung K; Kim J; He Y; Yin D; Bohl C; Dalton JT; Miller DD J Med Chem; 2004 Feb; 47(4):993-8. PubMed ID: 14761201 [TBL] [Abstract][Full Text] [Related]
17. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure. Fragkaki AG; Angelis YS; Koupparis M; Tsantili-Kakoulidou A; Kokotos G; Georgakopoulos C Steroids; 2009 Feb; 74(2):172-97. PubMed ID: 19028512 [TBL] [Abstract][Full Text] [Related]
18. Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators. Martinborough E; Shen Y; Oeveren Av; Long YO; Lau TL; Marschke KB; Chang WY; López FJ; Vajda EG; Rix PJ; Viveros OH; Negro-Vilar A; Zhi L J Med Chem; 2007 Oct; 50(21):5049-52. PubMed ID: 17887661 [TBL] [Abstract][Full Text] [Related]
19. Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activity. Long YO; Higuchi RI; Caferro TR; Lau TL; Wu M; Cummings ML; Martinborough EA; Marschke KB; Chang WY; López FJ; Karanewsky DS; Zhi L Bioorg Med Chem Lett; 2008 May; 18(9):2967-71. PubMed ID: 18400499 [TBL] [Abstract][Full Text] [Related]
20. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators. Piatnitski Chekler EL; Unwalla R; Khan TA; Tangirala RS; Johnson M; St Andre M; Anderson JT; Kenney T; Chiparri S; McNally C; Kilbourne E; Thompson C; Nagpal S; Weber G; Schelling S; Owens J; Morris CA; Powell D; Verhoest PR; Gilbert AM J Med Chem; 2014 Mar; 57(6):2462-71. PubMed ID: 24527807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]